Cidara Therapeutics Inc. (CDTX)
Cidara Therapeutics Statistics
Share Statistics
Cidara Therapeutics has 12.97M shares outstanding. The number of shares has increased by 140.12% in one year.
| 12.97M |
| 140.12% |
| 55.44% |
| 99.99% |
| n/a |
| 96 |
| 0.06% |
Short Selling Information
The latest short interest is 445.33K, so 3.43% of the outstanding shares have been sold short.
| 445.33K |
| 3.43% |
| 3.44% |
| 4.33 |
Valuation Ratios
The PE ratio is -1.01 and the forward PE ratio is -2.66. Cidara Therapeutics's PEG ratio is 0.
| -1.01 |
| -2.66 |
| 133.87 |
| 2.4 |
| 1.05 |
| -0.97 |
| 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cidara Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.02.
| 4.25 |
| 4.25 |
| 0.02 |
| -0.02 |
| -0.02 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $33,552.63 |
| $-4,469,131.58 |
| 38 |
| 0.01 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 96.32% in the last 52 weeks. The beta is 0.8, so Cidara Therapeutics's price volatility has been higher than the market average.
| 0.8 |
| 96.32% |
| 21.01 |
| 18.42 |
| 57.34 |
| 160,976 |
Income Statement
In the last 12 months, Cidara Therapeutics had revenue of 1.27M and earned -169.83M in profits. Earnings per share was -26.75.
| 1.27M |
| 1.04M |
| -176.1M |
| -169.83M |
| -176.1M |
| -176.1M |
| -26.75 |
Balance Sheet
The company has 189.82M in cash and 3.58M in debt, giving a net cash position of 186.25M.
| 189.82M |
| 3.58M |
| 186.25M |
| -611.26M |
| 191.73M |
| 140.04M |
Cash Flow
In the last 12 months, operating cash flow was -176.53M and capital expenditures -129K, giving a free cash flow of -176.66M.
| -176.53M |
| -129K |
| -176.66M |
| -27.82 |
Margins
Gross margin is 81.73%, with operating and profit margins of -13811.92% and -13319.76%.
| 81.73% |
| -13811.92% |
| -13356.16% |
| -13319.76% |
| -13811.92% |
| -13811.92% |
| -13855.84% |
Dividends & Yields
CDTX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CDTX is $45, which is 83.4% higher than the current price. The consensus rating is "Strong Buy".
| $45 |
| 83.4% |
| Strong Buy |
| 8 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Apr 24, 2024. It was a backward split with a ratio of 1:20.
| Apr 24, 2024 |
| backward |
| 1:20 |
Scores
| -2.09 |
| 1 |